Renal Disease Therapeutics Market by Application (Kidney Stone Disease, End-Stage Kidney Disease, Kidney Failure, Chronic Kidney Disease, Hypertension, Diabetes, Anaemia), by Treatment Devices (Dialysis Equipment, Renal Denervation devices, Wearable artificial kidney device, distal embolic protection devices) and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Renal Disease Therapeutics Market by Application (Kidney Stone Disease, End-Stage Kidney Disease, Kidney Failure, Chronic Kidney Disease, Hypertension, Diabetes, Anaemia), by Treatment Devices (Dialysis Equipment, Renal Denervation devices, Wearable artificial kidney device, distal embolic protection devices) and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 1291 | Pages: 181 | November 2016 | Region: Global


Renal Disease Therapeutics Market was worth $ xxx billion in 2016 and estimated to reach $ xxx billion by the end of 2021 with a CAGR of xxx %. Renal diseases are a progressive loss of proper functioning of the kidneys and associated renal system over a longer period of time is fueling the market because of its high incidence rate worldwide.

The kidneys have a number of life-sustaining functions, such as cleansing blood by filtering waste products and excess fluid, regulating blood pressure, and maintaining the balance of salt and minerals. When the kidney failure occurs, they ultimately lose their vital function, which is fatal. Kidney damage/failure can be developed acutely (AKI) and over the time (CKD). Three types of treatment are most prevalent to cure the kidney failure: prescription medications, surgical intervention, dialysis (peritoneal dialysis, hemodialysis, and continuous renal replacement therapy), which are frequently used in combination to treat a single case of renal failure.

Some of the key drivers of Renal Disease Therapeutics Market are increasing aging population, growing awareness of both acute and chronic kidney disease, and increasing number of individuals with insurance due to the Affordable Care Act, Increasing Diabetic Population, and growing demand for the advanced diagnostics and therapeutics for the disease. Disparities of Renal Transplant Therapy, expiring of patents of some of the branded drugs for the late stage CKD and changing reimbursement scenario in some of major countries, Negative Societal Effects are the restraints that are hindering the growth of the market.

The Renal Disease Therapeutics market is segmented based on the Application, and treatment. Application mode is segmented into Kidney Stone Disease, End-Stage Kidney Disease, Kidney Failure, Chronic Kidney Disease, Hypertension, Diabetes, and Anaemia. The treatment segment is further categorized into Dialysis Equipment, Renal Denervation devices, Wearable artificial kidney device, and distal embolic protection devices. On the basis of geography, the global market is analysed under various regions namely North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa. As of now, North America region dominates the global Renal Disease Therapeutics market. Europe comes next. However, the Asia-Pacific is projected to show highest CAGR over the forecast period owing to increasing number of high blood pressure and diabetic patients and growing demand for advanced diagnostics and therapeutics in the region.

Some of the major players in this market are Amgen Inc., Merck & Co., Inc., Bristol-Myers Squibb Company, Hoffmann-La Roche Inc., Shire Inc., Fresenius Medical Care, Baxter International, Davita Healthcare Partners.

1.Introduction                  

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods           

                1.4 General Study Assumptions

2. Research Methodology                           

                2.1 Introduction              

                2.2 Research Phases      

                                2.2.1 Secondary Research

                                2.2.2 Primary Research

                                2.2.3 Econometric Modelling

                                2.2.4 Expert Validation

                2.3 Analysis Design         

                2.4 Study Timeline          

3. Overview                      

                3.1 Executive Summary

                3.2 Key Inferences         

                3.3 Epidemology             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers          

                4.2 Market Restraints    

                4.3 Key Challenges         

                4.4 Current Opportunities in the Market

5. Market Segmentation                              

                5.1 Application 

                                5.1.1 Introduction

                                5.1.2 Kidney Stone Disease

                                5.1.3 End-Stage Kidney Disease

                                5.1.4 Kidney Failure

                                5.1.5 Chronic Kidney Disease

                                5.1.6 Hypertension

                                5.1.7 Diabetes

                                5.1.8 Anaemia

                                5.1.4 Y-o-Y Growth Analysis, By Application

                                5.1.5 Market Attractiveness Analysis, By Application

                                5.1.6 Market Share Analysis, By Application

                5.2 Treatment devices  

                                5.2.1 Introduction

                                5.2.2 Dialysis Equipment

                                5.2.3 Renal Denervation devices

                                5.2.4 Wearable artificial kidney device

                                5.2.5 distal embolic protection devices

                                5.2.6 Y-o-Y Growth Analysis, By Treatment devices

                                5.2.7 Market Attractiveness Analysis, By Treatment devices

                                5.2.8 Market Share Analysis, By Treatment devices

6. Geographical Analysis                              

                6.1 Introduction              

                                6.1.1 Regional Trends

                                6.1.2 Impact Analysis

                                6.1.3 Y-o-Y Growth Analysis

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Application

                                                6.1.3.3 By Treatment Devices

                                6.1.4 Market Attractiveness Analysis

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Application

                                                6.1.4.3 By Treatment devices

                                6.1.5 Market Share Analysis

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Application

                                                6.1.5.3 By Treatmentr Devices  

                6.2 North America          

                                6.1.1 Introduction

                                6.1.2 United States

                                6.1.3 Canada 

                6.3 Europe         

                                6.2.1 Introduction

                                6.2.2 U.K

                                6.2.3 Spain

                                6.2.4 Germany

                                6.2.5 Italy 

                                6.2.6 France

                6.4 Asia-Pacific 

                                6.3.1 Introduction

                                6.3.2 China 

                                6.3.3 India 

                                6.3.4 Japan 

                                6.3.5 Australia

                                6.3.6 South Korea

                6.5 Latin America            

                                6.4.1 Introduction

                                6.4.2 Brazil

                                6.4.3 Argentina

                                6.4.4 Mexico

                                6.4.5 Rest of Latin America

                6.6 Middle East & Africa

                                6.5.1 Introduction

                                6.5.2 Middle-East

                                6.5.3 Africa

7.Strategic Analysis                        

                7.1 PESTLE analysis         

                                7.1.1 Political

                                7.1.2 Economic

                                7.1.3 Social

                                7.1.4 Technological

                                7.1.5 Legal

                                7.1.6 Environmental

                7.2 Porter’s Five analysis              

                                7.2.1 Bargaining Power of Suppliers

                                7.2.2 Bargaining Power of Consumers

                                7.2.3 Threat of New Entrants

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry

8.Market Leaders' Analysis                          

                8.1 Amgen Inc. 

                                8.1.1 Overview

                                8.1.2 Product Analysis

                                8.1.3 Financial analysis

                                8.1.4 Recent Developments

                                8.1.5 SWOT analysis

                                8.1.6 Analyst View

                8.2 Merck & Co., Inc.     

                8.3 Bristol-Myers Squibb Company          

                8.4 Hoffmann-La Roche Inc         

                8.5 Shire Inc.     

                8.6 Fresenius Medical Care         

                8.7 Baxter International

                8.8 Davita Healthcare Partners  

9.Competitive Landscape                            

                9.1 Market share analysis            

                9.2 Merger and Acquisition Analysis        

                9.3 Agreements, collaborations and Joint Ventures          

                9.4 New Product Launches          

10.Market Outlook and Investment Opportunities                           

Appendix                           

                a) List of Tables

                b) List of Figures              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Global Diabetes Care Devices Market By Region, From 2016-2021 ( USD Million )
  2. Global Diabetes Care Devices Market By Application, From 2016-2021 ( USD Million )
  3. Global Kidney Stone Disease Market By Region, From 2016-2021 ( USD Million )
  4. Global End-Stage Kidney Disease Market By Region, From 2016-2021 ( USD Million )
  5. Global Kidney Failure Market By Region, From 2016-2021 ( USD Million )
  6. Global Chronic Kidney Disease Market By Region, From 2016-2021 ( USD Million )
  7. Global Hypertension Market By Region, From 2016-2021 ( USD Million )
  8. Global Diabetes Market By Region, From 2016-2021 ( USD Million )
  9. Global Anaemia Market By Region, From 2016-2021 ( USD Million )
  10. Global Diabetes Care Devices Market By Treatment Devices, From 2016-2021 ( USD Million )
  11. Global Dialysis Equipment Market By Region, From 2016-2021 ( USD Million )
  12. Global Renal Denervation Devices Market By Region, From 2016-2021 ( USD Million )
  13. Global Wearable Artificial Kidney Device Market By Region, From 2016-2021 ( USD Million )
  14. Global Distal Embolic Protection Devices Market By Region, From 2016-2021 ( USD Million )
  15. Global Distal Embolic Protection Devices Market By Region, From 2016-2021 ( USD Million )
  16. North America Diabetes Care Devices Market By Application, From 2016-2021 ( USD Million )
  17. North America Kidney Stone Disease Market By Region, From 2016-2021 ( USD Million )
  18. North America End-Stage Kidney Disease Market By Region, From 2016-2021 ( USD Million )
  19. North America Kidney Failure Market By Region, From 2016-2021 ( USD Million )
  20. North America Chronic Kidney Disease Market By Region, From 2016-2021 ( USD Million )
  21. North America Hypertension Market By Region, From 2016-2021 ( USD Million )
  22. North America Diabetes Market By Region, From 2016-2021 ( USD Million )
  23. North America Anaemia Market By Region, From 2016-2021 ( USD Million )
  24. North America Diabetes Care Devices Market By Treatment Devices, From 2016-2021 ( USD Million )
  25. North America Dialysis Equipment Market By Region, From 2016-2021 ( USD Million )
  26. North America Renal Denervation Devices Market By Region, From 2016-2021 ( USD Million )
  27. North America Wearable Artificial Kidney Device Market By Region, From 2016-2021 ( USD Million )
  28. North America Distal Embolic Protection Devices Market By Region, From 2016-2021 ( USD Million )
  29. North America Distal Embolic Protection Devices Market By Region, From 2016-2021 ( USD Million )
  30. United States Diabetes Care Devices Market By Application, From 2016-2021 ( USD Million )
  31. United States Diabetes Care Devices Market By Treatment Devices, From 2016-2021 ( USD Million )
  32. Canada Diabetes Care Devices Market By Application, From 2016-2021 ( USD Million )
  33. Canada Diabetes Care Devices Market By Treatment Devices, From 2016-2021 ( USD Million )
  34. Europe Diabetes Care Devices Market By Application, From 2016-2021 ( USD Million )
  35. Europe Kidney Stone Disease Market By Region, From 2016-2021 ( USD Million )
  36. Europe End-Stage Kidney Disease Market By Region, From 2016-2021 ( USD Million )
  37. Europe Kidney Failure Market By Region, From 2016-2021 ( USD Million )
  38. Europe Chronic Kidney Disease Market By Region, From 2016-2021 ( USD Million )
  39. Europe Hypertension Market By Region, From 2016-2021 ( USD Million )
  40. Europe Diabetes Market By Region, From 2016-2021 ( USD Million )
  41. Europe Anaemia Market By Region, From 2016-2021 ( USD Million )
  42. Europe Diabetes Care Devices Market By Treatment Devices, From 2016-2021 ( USD Million )
  43. Europe Dialysis Equipment Market By Region, From 2016-2021 ( USD Million )
  44. Europe Renal Denervation Devices Market By Region, From 2016-2021 ( USD Million )
  45. Europe Wearable Artificial Kidney Device Market By Region, From 2016-2021 ( USD Million )
  46. Europe Distal Embolic Protection Devices Market By Region, From 2016-2021 ( USD Million )
  47. Europe Distal Embolic Protection Devices Market By Region, From 2016-2021 ( USD Million )
  48. U.K. Diabetes Care Devices Market By Application, From 2016-2021 ( USD Million )
  49. U.K. Diabetes Care Devices Market By Treatment Devices, From 2016-2021 ( USD Million )
  50. Germany Diabetes Care Devices Market By Application, From 2016-2021 ( USD Million )
  51. Germany Diabetes Care Devices Market By Treatment Devices, From 2016-2021 ( USD Million )
  52. France Diabetes Care Devices Market By Application, From 2016-2021 ( USD Million )
  53. France Diabetes Care Devices Market By Treatment Devices, From 2016-2021 ( USD Million )
  54. Italy Diabetes Care Devices Market By Application, From 2016-2021 ( USD Million )
  55. Italy Diabetes Care Devices Market By Treatment Devices, From 2016-2021 ( USD Million )
  56. Spain Diabetes Care Devices Market By Application, From 2016-2021 ( USD Million )
  57. Spain Diabetes Care Devices Market By Treatment Devices, From 2016-2021 ( USD Million )
  58. Asia-Pacific Diabetes Care Devices Market By Application, From 2016-2021 ( USD Million )
  59. Asia-Pacific Kidney Stone Disease Market By Region, From 2016-2021 ( USD Million )
  60. Asia-Pacific End-Stage Kidney Disease Market By Region, From 2016-2021 ( USD Million )
  61. Asia-Pacific Kidney Failure Market By Region, From 2016-2021 ( USD Million )
  62. Asia-Pacific Chronic Kidney Disease Market By Region, From 2016-2021 ( USD Million )
  63. Asia-Pacific Hypertension Market By Region, From 2016-2021 ( USD Million )
  64. Asia-Pacific Diabetes Market By Region, From 2016-2021 ( USD Million )
  65. Asia-Pacific Anaemia Market By Region, From 2016-2021 ( USD Million )
  66. Asia-Pacific Diabetes Care Devices Market By Treatment Devices, From 2016-2021 ( USD Million )
  67. Asia-Pacific Dialysis Equipment Market By Region, From 2016-2021 ( USD Million )
  68. Asia-Pacific Renal Denervation Devices Market By Region, From 2016-2021 ( USD Million )
  69. Asia-Pacific Wearable Artificial Kidney Device Market By Region, From 2016-2021 ( USD Million )
  70. Asia-Pacific Distal Embolic Protection Devices Market By Region, From 2016-2021 ( USD Million )
  71. Asia-Pacific Distal Embolic Protection Devices Market By Region, From 2016-2021 ( USD Million )
  72. Japan Diabetes Care Devices Market By Application, From 2016-2021 ( USD Million )
  73. Japan Diabetes Care Devices Market By Treatment Devices, From 2016-2021 ( USD Million )
  74. China Diabetes Care Devices Market By Application, From 2016-2021 ( USD Million )
  75. China Diabetes Care Devices Market By Treatment Devices, From 2016-2021 ( USD Million )
  76. India Diabetes Care Devices Market By Application, From 2016-2021 ( USD Million )
  77. India Diabetes Care Devices Market By Treatment Devices, From 2016-2021 ( USD Million )
  78. Australia Diabetes Care Devices Market By Application, From 2016-2021 ( USD Million )
  79. Australia Diabetes Care Devices Market By Treatment Devices, From 2016-2021 ( USD Million )
  80. South Korea Diabetes Care Devices Market By Application, From 2016-2021 ( USD Million )
  81. South Korea Diabetes Care Devices Market By Treatment Devices, From 2016-2021 ( USD Million )
  82. Latin America Diabetes Care Devices Market By Application, From 2016-2021 ( USD Million )
  83. Latin America Kidney Stone Disease Market By Region, From 2016-2021 ( USD Million )
  84. Latin America End-Stage Kidney Disease Market By Region, From 2016-2021 ( USD Million )
  85. Latin America Kidney Failure Market By Region, From 2016-2021 ( USD Million )
  86. Latin America Chronic Kidney Disease Market By Region, From 2016-2021 ( USD Million )
  87. Latin America Hypertension Market By Region, From 2016-2021 ( USD Million )
  88. Latin America Diabetes Market By Region, From 2016-2021 ( USD Million )
  89. Latin America Anaemia Market By Region, From 2016-2021 ( USD Million )
  90. Latin America Diabetes Care Devices Market By Treatment Devices, From 2016-2021 ( USD Million )
  91. Latin America Dialysis Equipment Market By Region, From 2016-2021 ( USD Million )
  92. Latin America Renal Denervation Devices Market By Region, From 2016-2021 ( USD Million )
  93. Latin America Wearable Artificial Kidney Device Market By Region, From 2016-2021 ( USD Million )
  94. Latin America Distal Embolic Protection Devices Market By Region, From 2016-2021 ( USD Million )
  95. Latin America Distal Embolic Protection Devices Market By Region, From 2016-2021 ( USD Million )
  96. Brazil Diabetes Care Devices Market By Application, From 2016-2021 ( USD Million )
  97. Brazil Diabetes Care Devices Market By Treatment Devices, From 2016-2021 ( USD Million )
  98. Argentina Diabetes Care Devices Market By Application, From 2016-2021 ( USD Million )
  99. Argentina Diabetes Care Devices Market By Treatment Devices, From 2016-2021 ( USD Million )
  100. Mexico Diabetes Care Devices Market By Application, From 2016-2021 ( USD Million )
  101. Mexico Diabetes Care Devices Market By Treatment Devices, From 2016-2021 ( USD Million )
  102. Rest of Latin America Diabetes Care Devices Market By Application, From 2016-2021 ( USD Million )
  103. Rest of Latin America Diabetes Care Devices Market By Treatment Devices, From 2016-2021 ( USD Million )
  104. Middle East & Africa Diabetes Care Devices Market By Application, From 2016-2021 ( USD Million )
  105. Middle East & Africa Kidney Stone Disease Market By Region, From 2016-2021 ( USD Million )
  106. Middle East & Africa End-Stage Kidney Disease Market By Region, From 2016-2021 ( USD Million )
  107. Middle East & Africa Kidney Failure Market By Region, From 2016-2021 ( USD Million )
  108. Middle East & Africa Chronic Kidney Disease Market By Region, From 2016-2021 ( USD Million )
  109. Middle East & Africa Hypertension Market By Region, From 2016-2021 ( USD Million )
  110. Middle East & Africa Diabetes Market By Region, From 2016-2021 ( USD Million )
  111. Middle East & Africa Anaemia Market By Region, From 2016-2021 ( USD Million )
  112. Middle East & Africa Diabetes Care Devices Market By Treatment Devices, From 2016-2021 ( USD Million )
  113. Middle East & Africa Dialysis Equipment Market By Region, From 2016-2021 ( USD Million )
  114. Middle East & Africa Renal Denervation Devices Market By Region, From 2016-2021 ( USD Million )
  115. Middle East & Africa Wearable Artificial Kidney Device Market By Region, From 2016-2021 ( USD Million )
  116. Middle East & Africa Distal Embolic Protection Devices Market By Region, From 2016-2021 ( USD Million )
  117. Middle East & Africa Distal Embolic Protection Devices Market By Region, From 2016-2021 ( USD Million )
  118. Middle East Diabetes Care Devices Market By Application, From 2016-2021 ( USD Million )
  119. Middle East Diabetes Care Devices Market By Treatment Devices, From 2016-2021 ( USD Million )
  120. Africa Diabetes Care Devices Market By Application, From 2016-2021 ( USD Million )
  121. Africa Diabetes Care Devices Market By Treatment Devices, From 2016-2021 ( USD Million )
Middle East and Africa Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Servic...
Latin America Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Services, Unski...
Asia-Pacific Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Services, Unskil...
Europe Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Services, Unskilled Ca...
North America Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Services, Unski...
Home Healthcare Market by Product (Mobility Care Products ,Screening, & Monitoring Products, Testing, Therapeutic Products) by Service (Infusion Therapy Services, Rehabilitation Therapy Services, Unskilled Care Serv...
Middle East and Africa Thyroid cancer Market by Treatment (surgery, iodine therapy, External radiotherapy, Thyroxin treatment, chemotherapy, Drugs) by End user(Hospital, Oncology centers, Hospital Pharmacies and Ret...
Latin America Thyroid Cancer Market by Treatment (surgery, iodine therapy, External radiotherapy, Thyroxin treatment, chemotherapy, Drugs) by End user(Hospital, Oncology centers, Hospital Pharmacies and Retail Pharm...
Asia Pacific Thyroid cancer Market by Treatment (surgery, iodine therapy, External radiotherapy, Thyroxin treatment, chemotherapy, Drugs) by End user(Hospital, Oncology centers, Hospital Pharmacies and Retail Pharma...
Europe Thyroid Cancer Market by Treatment (surgery, iodine therapy, External radiotherapy, Thyroxin treatment, chemotherapy, Drugs) by end user (Hospital, Oncology centers, Hospital Pharmacies and Retail Pharmacies....
North America Market Thyroid Cancer Market by Treatment (surgery, iodine therapy, External radiotherapy, Thyroxin treatment, chemotherapy, Drugs) by End user (Hospital, Oncology centers, Hospital Pharmacies and Reta...
Thyroid Cancer Market by Treatment (surgery, iodine therapy, External radiotherapy, Thyroxin treatment, chemotherapy, Drugs) by End user(Hospital, Oncology centers, Hospital Pharmacies and Retail Pharmacies.) and by...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
502, Kakatiya's Empire,
Jubilee Gardens, Hyderabad,
Telangana, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.